# Danaher Corp: financial statements, quarterly

DHR · NYSE · CIK 313616 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dhr.md) · [Financials](/companies/dhr/financials.md) · [Filings](/companies/dhr/filings.md) · [Insiders](/companies/dhr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dhr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-27) | Q2 FY2026 (2026-06-26) | Q3 FY2026 (2026-09-25) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,405](/filings/0000313616-24-000052.md) | [5,796](/filings/0000313616-25-000088.md) | [5,743](/filings/0000313616-25-000153.md) | [5,798](/filings/0000313616-25-000182.md) | [6,538 d](/filings/0000313616-26-000062.md) | [5,741](/filings/0000313616-26-000107.md) | [5,936](/filings/0000313616-26-000161.md) | [6,053](/filings/0000313616-26-000199.md) | [6,838 d](/filings/0000313616-26-000062.md) | [5,951](/filings/0000313616-26-000107.md) | [6,265](/filings/0000313616-26-000161.md) | [6,554](/filings/0000313616-26-000199.md) |
| Cost of revenue | $m | [2,626 d](/filings/0000313616-26-000062.md) | [2,309](/filings/0000313616-25-000088.md) | [2,315](/filings/0000313616-25-000153.md) | [2,397](/filings/0000313616-25-000182.md) | [2,648 d](/filings/0000313616-26-000062.md) | [2,230](/filings/0000313616-26-000107.md) | [2,413](/filings/0000313616-26-000161.md) | [2,530](/filings/0000313616-26-000199.md) | [2,872 d](/filings/0000313616-26-000062.md) | [2,360](/filings/0000313616-26-000107.md) | [2,654](/filings/0000313616-26-000161.md) | [2,717](/filings/0000313616-26-000199.md) |
| Gross profit | $m | [3,779](/filings/0000313616-24-000052.md) | [3,487](/filings/0000313616-25-000088.md) | [3,428](/filings/0000313616-25-000153.md) | [3,401](/filings/0000313616-25-000182.md) | [3,890 d](/filings/0000313616-26-000062.md) | [3,511](/filings/0000313616-26-000107.md) | [3,523](/filings/0000313616-26-000161.md) | [3,523](/filings/0000313616-26-000199.md) | [3,966 d](/filings/0000313616-26-000062.md) | [3,591](/filings/0000313616-26-000107.md) | [3,611](/filings/0000313616-26-000161.md) | [3,837](/filings/0000313616-26-000199.md) |
| Research and development | $m | [407 d](/filings/0000313616-26-000062.md) | [368](/filings/0000313616-25-000088.md) | [391](/filings/0000313616-25-000153.md) | [383](/filings/0000313616-25-000182.md) | [442 d](/filings/0000313616-26-000062.md) | [379](/filings/0000313616-26-000107.md) | [403](/filings/0000313616-26-000161.md) | [378](/filings/0000313616-26-000199.md) | [438 d](/filings/0000313616-26-000062.md) | [387](/filings/0000313616-26-000107.md) | [412](/filings/0000313616-26-000161.md) | [433](/filings/0000313616-26-000199.md) |
| Selling, general and administrative | $m | [2,035 d](/filings/0000313616-26-000062.md) | [1,807](/filings/0000313616-25-000088.md) | [1,869](/filings/0000313616-25-000153.md) | [2,060](/filings/0000313616-25-000182.md) | [2,023 d](/filings/0000313616-26-000062.md) | [1,858](/filings/0000313616-26-000107.md) | [2,360](/filings/0000313616-26-000161.md) | [1,991](/filings/0000313616-26-000199.md) | [2,026 d](/filings/0000313616-26-000062.md) | [1,860](/filings/0000313616-26-000107.md) | [2,072](/filings/0000313616-26-000161.md) | [2,159](/filings/0000313616-26-000199.md) |
| Operating income | $m | [1,337](/filings/0000313616-24-000052.md) | [1,312](/filings/0000313616-25-000088.md) | [1,168](/filings/0000313616-25-000153.md) | [958](/filings/0000313616-25-000182.md) | [1,425 d](/filings/0000313616-26-000062.md) | [1,274](/filings/0000313616-26-000107.md) | [760](/filings/0000313616-26-000161.md) | [1,154](/filings/0000313616-26-000199.md) | [1,502 d](/filings/0000313616-26-000062.md) | [1,344](/filings/0000313616-26-000107.md) | [1,127](/filings/0000313616-26-000161.md) | [1,245](/filings/0000313616-26-000199.md) |
| Interest expense | $m | [78.0 d](/filings/0000313616-24-000052.md) | [65.0](/filings/0000313616-24-000102.md) | [65.0](/filings/0000313616-25-000153.md) | [87.0](/filings/0000313616-25-000182.md) | [61.0 d](/filings/0000313616-26-000062.md) | [72.0](/filings/0000313616-26-000107.md) | [71.0](/filings/0000313616-26-000161.md) | [67.0](/filings/0000313616-26-000199.md) | [55.0 d](/filings/0000313616-26-000062.md) | [63.0](/filings/0000313616-26-000107.md) | [107](/filings/0000313616-26-000161.md) | [135](/filings/0000313616-26-000199.md) |
| Income tax | $m | [111 d](/filings/0000313616-26-000062.md) | [183](/filings/0000313616-25-000088.md) | [176](/filings/0000313616-25-000153.md) | [159](/filings/0000313616-25-000182.md) | [229 d](/filings/0000313616-26-000062.md) | [175](/filings/0000313616-26-000107.md) | [100](/filings/0000313616-26-000161.md) | [168](/filings/0000313616-26-000199.md) | [190 d](/filings/0000313616-26-000062.md) | [206](/filings/0000313616-26-000107.md) | [208](/filings/0000313616-26-000161.md) | [(75.0)](/filings/0000313616-26-000199.md) |
| Net income | $m | [1,079](/filings/0000313616-24-000052.md) | [1,088](/filings/0000313616-25-000088.md) | [907](/filings/0000313616-25-000153.md) | [818](/filings/0000313616-25-000182.md) | [1,086 d](/filings/0000313616-26-000062.md) | [954](/filings/0000313616-26-000107.md) | [555](/filings/0000313616-26-000161.md) | [908](/filings/0000313616-26-000199.md) | [1,197 d](/filings/0000313616-26-000062.md) | [1,029](/filings/0000313616-26-000107.md) | [870](/filings/0000313616-26-000161.md) | [1,235](/filings/0000313616-26-000199.md) |
| Diluted EPS | $ per share | [1.45](/filings/0000313616-24-000052.md) | [1.45](/filings/0000313616-25-000088.md) | [1.22](/filings/0000313616-25-000153.md) | [1.12](/filings/0000313616-25-000182.md) | not reported | [1.32](/filings/0000313616-26-000107.md) | [0.77](/filings/0000313616-26-000161.md) | [1.27](/filings/0000313616-26-000199.md) | not reported | [1.45](/filings/0000313616-26-000107.md) | [1.23](/filings/0000313616-26-000161.md) | [1.75](/filings/0000313616-26-000199.md) |
| Basic EPS | $ per share | [1.46](/filings/0000313616-24-000052.md) | [1.47](/filings/0000313616-25-000088.md) | [1.23](/filings/0000313616-25-000153.md) | [1.13](/filings/0000313616-25-000182.md) | not reported | [1.33](/filings/0000313616-26-000107.md) | [0.77](/filings/0000313616-26-000161.md) | [1.28](/filings/0000313616-26-000199.md) | not reported | [1.45](/filings/0000313616-26-000107.md) | [1.23](/filings/0000313616-26-000161.md) | [1.75](/filings/0000313616-26-000199.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-27) | Q2 FY2026 (2026-06-26) | Q3 FY2026 (2026-09-25) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $bn | [13.9](/filings/0000313616-25-000043.md) | [14.4](/filings/0000313616-24-000102.md) | [9.6](/filings/0000313616-24-000186.md) | [10.1](/filings/0000313616-24-000220.md) | [9.5](/filings/0000313616-26-000062.md) | [9.5](/filings/0000313616-25-000088.md) | [11.0](/filings/0000313616-25-000153.md) | [9.6](/filings/0000313616-25-000182.md) | [12.8](/filings/0000313616-26-000199.md) | [13.9](/filings/0000313616-26-000107.md) | [13.4](/filings/0000313616-26-000161.md) | [14.8](/filings/0000313616-26-000199.md) |
| Total assets | $bn | [84.5](/filings/0000313616-26-000062.md) | [83.4](/filings/0000313616-24-000102.md) | [78.6](/filings/0000313616-24-000186.md) | [80.6](/filings/0000313616-24-000220.md) | [77.5](/filings/0000313616-26-000062.md) | [79.1](/filings/0000313616-25-000088.md) | [81.6](/filings/0000313616-25-000153.md) | [79.9](/filings/0000313616-25-000182.md) | [83.5](/filings/0000313616-26-000199.md) | [83.5](/filings/0000313616-26-000107.md) | [92.4](/filings/0000313616-26-000161.md) | [93.3](/filings/0000313616-26-000199.md) |
| Current liabilities | $bn | [8.3](/filings/0000313616-25-000043.md) | [7.8](/filings/0000313616-24-000102.md) | [6.7](/filings/0000313616-24-000186.md) | [7.3](/filings/0000313616-24-000220.md) | [6.8](/filings/0000313616-26-000062.md) | [6.6](/filings/0000313616-25-000088.md) | [6.8](/filings/0000313616-25-000153.md) | [6.3](/filings/0000313616-25-000182.md) | [6.8](/filings/0000313616-26-000199.md) | [7.5](/filings/0000313616-26-000107.md) | [8.1](/filings/0000313616-26-000161.md) | [9.1](/filings/0000313616-26-000199.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $bn | [16.7](/filings/0000313616-25-000043.md) | [16.4](/filings/0000313616-24-000102.md) | [16.3](/filings/0000313616-24-000186.md) | [16.3](/filings/0000313616-24-000220.md) | [15.5](/filings/0000313616-26-000062.md) | [16.0](/filings/0000313616-25-000088.md) | [16.9](/filings/0000313616-25-000153.md) | [16.8](/filings/0000313616-25-000182.md) | [18.4](/filings/0000313616-26-000199.md) | [17.6](/filings/0000313616-26-000107.md) | [25.1](/filings/0000313616-26-000161.md) | [24.4](/filings/0000313616-26-000199.md) |
| Current portion of debt | $bn | [1.7](/filings/0000313616-25-000043.md) | [1.7](/filings/0000313616-24-000102.md) | [0.7](/filings/0000313616-24-000186.md) | [1.2](/filings/0000313616-24-000220.md) | [0.5](/filings/0000313616-26-000062.md) | [0.5](/filings/0000313616-25-000088.md) | [0.5](/filings/0000313616-25-000153.md) | [0.0](/filings/0000313616-25-000182.md) | [0.0](/filings/0000313616-26-000199.md) | [0.9](/filings/0000313616-26-000107.md) | [1.4](/filings/0000313616-26-000161.md) | [2.1](/filings/0000313616-26-000199.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [53.5](/filings/0000313616-25-000043.md) | [53.4](/filings/0000313616-24-000102.md) | [49.9](/filings/0000313616-24-000186.md) | [51.3](/filings/0000313616-24-000220.md) | [49.5](/filings/0000313616-26-000062.md) | [50.8](/filings/0000313616-25-000088.md) | [52.3](/filings/0000313616-25-000153.md) | [51.1](/filings/0000313616-25-000182.md) | [52.5](/filings/0000313616-26-000199.md) | [52.9](/filings/0000313616-26-000107.md) | [52.6](/filings/0000313616-26-000161.md) | [53.6](/filings/0000313616-26-000199.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-27) | Q2 FY2026 (2026-06-26) | Q3 FY2026 (2026-09-25) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,619 d](/filings/0000313616-26-000062.md) | [1,739](/filings/0000313616-25-000088.md) | [1,417 d](/filings/0000313616-25-000153.md) | [1,513 d](/filings/0000313616-25-000182.md) | [2,019 d](/filings/0000313616-26-000062.md) | [1,299](/filings/0000313616-26-000107.md) | [1,338 d](/filings/0000313616-26-000161.md) | [1,662 d](/filings/0000313616-26-000199.md) | [2,117 d](/filings/0000313616-26-000062.md) | [1,322](/filings/0000313616-26-000107.md) | [1,534 d](/filings/0000313616-26-000161.md) | [1,886 d](/filings/0000313616-26-000199.md) |
| Capital expenditure | $m | [434 d](/filings/0000313616-26-000062.md) | [291](/filings/0000313616-25-000088.md) | [287 d](/filings/0000313616-25-000153.md) | [298 d](/filings/0000313616-25-000182.md) | [516 d](/filings/0000313616-26-000062.md) | [245](/filings/0000313616-26-000107.md) | [248 d](/filings/0000313616-26-000161.md) | [292 d](/filings/0000313616-26-000199.md) | [371 d](/filings/0000313616-26-000062.md) | [237](/filings/0000313616-26-000107.md) | [269 d](/filings/0000313616-26-000161.md) | [255 d](/filings/0000313616-26-000199.md) |
| Dividends paid | $m | [200 d](/filings/0000313616-26-000062.md) | [177](/filings/0000313616-25-000088.md) | [200 d](/filings/0000313616-25-000153.md) | [196 d](/filings/0000313616-25-000182.md) | [195 d](/filings/0000313616-26-000062.md) | [194](/filings/0000313616-26-000107.md) | [229 d](/filings/0000313616-26-000161.md) | [229 d](/filings/0000313616-26-000199.md) | [226 d](/filings/0000313616-26-000062.md) | [226](/filings/0000313616-26-000107.md) | [283 d](/filings/0000313616-26-000161.md) | [281 d](/filings/0000313616-26-000199.md) |
| Share repurchases | $m | [0.0 d](/filings/0000313616-26-000062.md) | [0.0](/filings/0000313616-25-000088.md) | [4,530 d](/filings/0000313616-25-000153.md) | [640 d](/filings/0000313616-25-000182.md) | [809 d](/filings/0000313616-26-000062.md) | [1,078](/filings/0000313616-26-000107.md) | [0.0 d](/filings/0000313616-26-000161.md) | [2,010 d](/filings/0000313616-26-000199.md) | [0.0 d](/filings/0000313616-26-000062.md) | [0.0](/filings/0000313616-26-000107.md) | [894 d](/filings/0000313616-26-000161.md) | [0.0 d](/filings/0000313616-26-000199.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q1 FY2026 (2026-03-27) | Q2 FY2026 (2026-06-26) | Q3 FY2026 (2026-09-25) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [737](/filings/0000313616-24-000102.md) | [745](/filings/0000313616-24-000186.md) | [746](/filings/0000313616-24-000220.md) | [749](/filings/0000313616-25-000088.md) | [742](/filings/0000313616-25-000153.md) | [729](/filings/0000313616-25-000182.md) | [721](/filings/0000313616-26-000107.md) | [719](/filings/0000313616-26-000161.md) | [714](/filings/0000313616-26-000199.md) | [711](/filings/0000313616-26-000107.md) | [708](/filings/0000313616-26-000161.md) | [707](/filings/0000313616-26-000199.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 703,530,815 at 2026-10-15, from the cover of the [10-Q filed 2026-10-21](/filings/0000313616-26-000199.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.